Resistance among Streptococcus pneumoniae: Patterns, mechanisms, interpreting the breakpoints

American Journal of Managed Care

Volumn 6, Issue 23 SUPPL., 2000, Pages

  Brueggemann, A B ^a   Doern, G V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFDINIR; CEFDITOREN; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CETHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; LORACARBEF; MACROLIDE; MOXIFLOXACIN; PENICILLIN BINDING PROTEIN; PENICILLIN G; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG INFORMATION; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0034524054     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study
2. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States
3. Pneumococcal resistance to antibiotics
4. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987
5. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S.
6. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-95
7. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98
8. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of B-lactam antibiotics
9. Alterations in PBP 1A essential for high-level penicillin resistance in Streptococcus pneumoniae
10. Interpretive criteria for in vitro antimicrobial susceptibility tests
11. Management of infections due to antibiotic-resistant Streptococcus pneumoniae
12. Minireview: Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae
13. The clinical relevance of antibiotic resistance in the management of pneumococcal pneumoniae
14. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain
15. Management of community-acquired pneumonia in the era of pneumococcal resistance
16. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
17. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995
18. Novel mechanism of macrolide resistance in Streptococcus pneumoniae
19. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides by sensitive to clindamycin: A common resistance pattern mediated by an efflux system
20. Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children
21. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
22. Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-98 respiratory season
23. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype
24. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae